KYTX
Kyverna Therapeutics Inc.
$6.93
+$0.30(+4.52%)
56
Overall
60
Value
75
Tech
34
Quality
Market Cap
$250.82M
Volume
320.48K
52W Range
$1.78 - $7.73
Target Price
$20.50
Key Metrics Overview
| Market Cap | $250.82M | P/E Ratio | N/A |
| 52W High | $7.73 | 52W Low | $1.78 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 77.1% | 52W Position | 86.6% |
| Overall Score | 56 | Value Score | 60 |
| Quality Score | 34 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-3.86 | EPS Next Est | $-3.67 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $6.93 | +4.5% | 320.48K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW